2025 HFSA Contemporary Issues in Heart Failure - OnDemand-Device Selection in AMI- and Non-AMI Cardiogenic Shock

Video Transcription

Video Summary

The speaker reviews device selection in AMI and non-AMI cardiogenic shock, emphasizing that shock is heterogeneous, rapidly evolving, and requires early staging, recognition, and reassessment. He highlights the importance of SCI staging, early labs, bedside echo, and, when appropriate, invasive hemodynamics with pulmonary artery catheter use. Cardiogenic shock care should focus on end-organ perfusion, congestion relief, and serial evaluation in the first 6–24 hours.<br /><br />Temporary mechanical support options are matched to patient phenotype and severity. Recent evidence supports micro-axial flow pumps in select patients with severe refractory STEMI-related shock, while routine use of intra-aortic balloon pump or VA ECMO is not recommended due to lack of survival benefit in trials. He also stresses complications of support devices, including bleeding, limb ischemia, renal injury, and infection.<br /><br />Finally, multidisciplinary shock teams, standardized protocols, and early planning for recovery, durable LVAD, transplant, or palliative care are associated with better outcomes.

Keywords

cardiogenic shock

AMI

non-AMI

mechanical circulatory support

pulmonary artery catheter

shock team